R. Miralbell

发表

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

J. Hendry, R. Miralbell, S. Roberts, 2012, International journal of radiation oncology, biology, physics.

Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients

H. Zaidi, O. Ratib, R. Miralbell, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy.

A. Rosset, R. Miralbell, F. Schmidlin, 2009, Clinics in oncology.

Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment.

R Miralbell, R. Miralbell, M. Rouzaud, 1998, International journal of radiation oncology, biology, physics.

Potential impact of improvements in radiation therapy on quality of life and survival.

R. Miralbell, H. Suit, 1989, International journal of radiation oncology, biology, physics.

Guidelines for primary radiotherapy of patients with prostate cancer.

Michel Bolla, Raymond Miralbell, Alberto Bossi, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.

Michel Bolla, Raymond Miralbell, Zvi Symon, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reproducibility of conformal radiation therapy in localized carcinoma of the prostate without rigid immobilization.

R Miralbell, S Bieri, R. Miralbell, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma

Habib Zaidi, Michel Rouzaud, Osman Ratib, 2022 .

Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma

H. Zaidi, O. Ratib, R. Miralbell, 2012, Radiation oncology.

18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer.

Habib Zaidi, Osman Ratib, Michael Wissmeyer, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Boosting the tumor bed from deep-seated tumors in early-stage breast cancer: a planning study between electron, photon, and proton beams.

L. Cozzi, R. Miralbell, A. Fogliata, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mild hyperthermia by MR-guided focused ultrasound in an ex vivo model of osteolytic bone tumour: optimization of the spatio-temporal control of the delivered temperature

X. Montet, R. Miralbell, L. Crowe, 2019, Journal of Translational Medicine.

Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review.

J. Vallée, R. Miralbell, T. Zilli, 2014, International journal of radiation oncology, biology, physics.

Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial

K. Herfarth, D. Song, T. DeWeese, 2014, Radiation oncology.

Automatic segmentation of breast in prone position: Correlation of similarity indexes and breast pendulousness with dose/volume parameters.

R. Miralbell, V. Vinh-Hung, Xinzhuo Wang, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis.

N. V. As, R. Miralbell, R. Orecchia, 2016, European urology.

Dose-escalated volumetric modulated arc therapy for total marrow irradiation: A feasibility dosimetric study with 4DCT planning and simultaneous integrated boost.

R. Miralbell, M. Jaccard, M. Rouzaud, 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.

O. Ratib, R. Miralbell, F. Buchegger, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graft.

R. Miralbell, B. Chapuis, P. Nouet, 1993, Bone marrow transplantation.

Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless Rooms

Juan Antonio Vera Sánchez, S. España, R. Miralbell, 2021, Frontiers in Oncology.

Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.

R. Miralbell, M. Jaccard, P. Poulsen, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).

L. Collette, Yan Liu, A. Pica, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

E. van Limbergen, H. Bartelink, J. Horiot, 2017, JAMA oncology.

Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison.

R. Miralbell, A. Allal, J. Kurtz, 1993, International journal of radiation oncology, biology, physics.

Radiation therapy and breast conservation: Cosmetic results and complications

R. Miralbell, J. Kurtz, 1992 .

Oligometastatic prostate cancer: The game is afoot.

R. Miralbell, S. Siva, N. Liefhooghe, 2019, Cancer treatment reviews.

Neck management in head and neck squamous cell carcinomas: where do we stand?

R. Miralbell, J. Thariat, F. Caparrotti, 2019, Medical Oncology.

Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.

J. Bourhis, R. Miralbell, M. Ozsahin, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values ( < 1 ng/mL) after radical prostatectomy

H. Zaidi, R. Miralbell, F. Buchegger, 2007 .

Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy.

M. Stracher, R. Miralbell, H. Mankin, 1990, International journal of radiation oncology, biology, physics.

18F‐choline and/or 11C‐acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate‐specific antigen values (<1 ng/mL) after radical prostatectomy

H. Zaidi, R. Miralbell, F. Buchegger, 2007, BJU international.

Recent trends in prostate cancer mortality show a continuous decrease in several countries

R. Miralbell, R. Zanetti, G. Fioretta, 2008, International journal of cancer.

Atlas Sampling for Prone Breast Automatic Segmentation of Organs at Risk: The Importance of Patients’ Body Mass Index and Breast Cup Size for an Optimized Contouring of the Heart and the Coronary Vessels

J. Vallée, R. Miralbell, Xinzhuo Wang, 2020, Technology in cancer research & treatment.

Results of Dose-adapted Salvage Radiotherapy After Radical Prostatectomy Based on an Endorectal MRI Target Definition Model

R. Miralbell, N. Péguret, F. Caparrotti, 2017, American journal of clinical oncology.

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma

G. Salles, J. Connors, F. Cavalli, 2020, International journal of environmental research and public health.

Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes?

R. Miralbell, M. Rouzaud, S. Bieri, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An 18F-MISO PET-MRI Study.

J. Vallée, R. Miralbell, V. Garibotto, 2017, International journal of radiation oncology, biology, physics.

The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy

C. Combescure, L. Rubbia‐Brandt, R. Miralbell, 2012, Radiation oncology.

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer

B. Seifert, P. Veit-Haibach, R. Miralbell, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

C-ACETATE PET/CT AT EARLY PSA RELAPSE AFTER PROSTATECTOMY

H. Zaidi, R. Miralbell, F. Buchegger, 2007 .

Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI

O. Ratib, C. Iselin, R. Miralbell, 2019, Medical Oncology.

Editorial Comment from Dr Zilli and Dr Miralbell to Early radiotherapy after radical prostatectomy improves cancer‐specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria

R. Miralbell, T. Zilli, 2015, International journal of urology : official journal of the Japanese Urological Association.

PET/CT imaging and the oligometastatic prostate cancer patient: an opportunity for a curative approach with high-dose radiotherapy?

R. Miralbell, F. Buchegger, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.

K. Herfarth, D. Song, E. Ford, 2013, International journal of radiation oncology, biology, physics.

Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.

J. Vallée, L. Cozzi, R. Miralbell, 2012, International journal of radiation oncology, biology, physics.

Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences.

R. Miralbell, R. Orecchia, F. Casamassima, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Short- and long-term mortality with localized prostate cancer.

H. Verkooijen, R. Miralbell, R. Zanetti, 2007, Archives of internal medicine.

Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature.

R. Miralbell, A. Dal Pra, T. Zilli, 2016, Cancer treatment reviews.

The role of radiotherapy in the treatment of subtotally resected benign meningiomas

R. Mirimanoff, R. Miralbell, J. Munzenrider, 1992, Journal of Neuro-Oncology.

Quality of life and social integration after allogeneic hematopoietic SCT

R. Miralbell, J. Passweg, B. Chapuis, 2008, Bone Marrow Transplantation.

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

O. Ratib, R. Miralbell, U. Schick, 2013, Acta oncologica.

First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy

H. Zaidi, O. Ratib, Y. Seimbille, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density

R. Miralbell, A. Probst, A. Sappino, 2004, Journal of Neuro-Oncology.

Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.

R. Miralbell, B. Chapuis, A. Keller, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis

H. Verkooijen, R. Miralbell, R. Zanetti, 2009, Cancer.

Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy.

E. Goetghebeur, R. Miralbell, F. Alongi, 2019, European urology.

Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation Approach

R. Miralbell, T. Zilli, T. Falco, 2018, American journal of clinical oncology.

Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer

H. Zaidi, O. Ratib, Y. Seimbille, 2017, Clinical nuclear medicine.

Recurrent Prostate Cancer

H. Zaidi, O. Ratib, Y. Seimbille, 2017 .

Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.

R. Miralbell, M. Rouzaud, T. Zilli, 2016, International journal of radiation oncology, biology, physics.

Pediatric medulloblastoma: radiation treatment technique and patterns of failure.

R. Mirimanoff, R. Miralbell, M. Notter, 1997, International journal of radiation oncology, biology, physics.

Clinical impact of (18)F-choline PET/CT in patients with recurrent prostate cancer

P. Veit-Haibach, R. Miralbell, H. Seifert, 2018 .

Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy

R. Miralbell, J. Thariat, M. Ozsahin, 2018, Medical Oncology.

Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomes.

R. Miralbell, 2011, Journal of radiosurgery and SBRT.

Can a total body irradiation technique be fast and reproducible?

R. Miralbell, M. Rouzaud, P. Nouet, 1994, International journal of radiation oncology, biology, physics.

Urinary toxicity after salvage re-irradiation for prostate cancer local failure after definitive radiotherapy: a clinical and dosimetric prognostic factors analysis

C. Fiorino, R. Miralbell, M. Rouzaud, 2022, Journal of contemporary brachytherapy.

Prostate cancer non-ascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: three case reports and review of the literature.

R. Miralbell, J. Tille, A. Friedlaender, 2019, Urology.

Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.

R. Pötter, D. Georg, A. Lomax, 2005, International journal of radiation oncology, biology, physics.

Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer.

R. Miralbell, D. Weber, M. Rouzaud, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Spacers entre prostate et rectum : optimisation des techniques d’irradiation du cancer de la prostate

R. Miralbell, T. Zilli, E. Benz, 2014 .

Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis

R. Miralbell, N. Péguret, F. Caparrotti, 2014, Acta oncologica.

Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

R. Miralbell, D. Weber, J. Kurtz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of patients with nonmetastatic muscle‐invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin‐based chemotherapy and/or radiotherapy: a retrospective analysis

M. Dimopoulos, A. Papatsoris, C. Iselin, 2016, Cancer medicine.

Hypofractionated Extracranial Stereotactic Radiotherapy Boost for Gynecologic Tumors: A Promising Alternative to High-Dose Rate Brachytherapy

R. Miralbell, M. Mollà, A. Hidalgo, 2010, Technology in cancer research & treatment.

Dose Escalation Study with Two Different Hypofractionated Intensity Modulated Radiotherapy Techniques for Localized Prostate Cancer: Acute Toxicity

R. Miralbell, D. Weber, M. Rouzaud, 2010, Technology in cancer research & treatment.

[Prostate-rectum spacers: optimization of prostate cancer irradiation].

R. Miralbell, T. Zilli, E. Benz, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Clinical experience with lung-specific electromagnetic transponders for real-time tumor tracking in lung stereotactic body radiotherapy

R. Miralbell, M. Jaccard, P. Soccal, 2019, Physics and imaging in radiation oncology.

Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT.

R. Miralbell, M. Jaccard, M. Rouzaud, 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide.

A. Rosset, P. Coucke, R. Miralbell, 1995, European journal of cancer.

Multiple Frame 18F-Fluorocholine or 11C-Acetate PET/CT Compared with Multi-modality MRI in Prostate Cancer Patients after Curative RT without Evidence of Relapse

O. Ratib, R. Miralbell, F. Buchegger, 2009 .

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.

E. van Limbergen, H. Bartelink, J. Horiot, 2015, The Lancet. Oncology.

Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.

C. Pichard, R. Miralbell, Y. Dupertuis, 2013, Clinical nutrition.

Incidental detection of synchronous primary tumours during staging workup for prostate cancer.

R. Miralbell, G. Fioretta, C. Ares, 2010, Swiss medical weekly.

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.

R. Miralbell, F. Lomeña, J. R. García, 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

11C-Choline PET/CT in the diagnosis of primary prostate cancer. Impact on treatment planning

R. Miralbell, F. Lomeña, M. Soler, 2013 .

Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.

R. Miralbell, M. Ozsahin, I. Carrió, 2004, International journal of radiation oncology, biology, physics.

Atlas-guided generation of pseudo-CT images for MRI-only and hybrid PET–MRI-guided radiotherapy treatment planning

Habib Zaidi, Hossein Arabi, Michel Rouzaud, 2016, Physics in medicine and biology.

Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.

M. Bolla, H. Bonnefoi, R. Miralbell, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models

C. Fiorino, R. Miralbell, M. Rouzaud, 2018, Advances in radiation oncology.

Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients

L. Cozzi, R. Miralbell, H. Vees, 2015, Technology in cancer research & treatment.

Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone.

P. Dulguerov, R. Miralbell, A. Allal, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.

Uwe Schneider, Laura Cella, Raymond Miralbell, 2002, International journal of radiation oncology, biology, physics.

Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams.

R Miralbell, A. Lomax, A. Lomax, 2000, International journal of radiation oncology, biology, physics.

Skin radionecrosis after percutaneous transluminal coronary angioplasty: dosimetric and biological assessment.

P. Doriot, R. Miralbell, N. Crompton, 1999, Journal of vascular and interventional radiology : JVIR.

The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network.

R. Miralbell, J. Kaanders, D. Aebersold, 2011, International journal of radiation oncology, biology, physics.

Effect of arytenoid sparing during radiation therapy of early stage glottic carcinoma.

R. Miralbell, A. Allal, W. Lehmann, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prone versus supine free-breathing for right-sided whole breast radiotherapy

R. Miralbell, V. Vinh-Hung, Xinzhuo Wang, 2022, Scientific reports.

Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A dosimetric analysis

R. Miralbell, V. Vinh-Hung, N. Nguyen, 2021, Strahlentherapie und Onkologie.

Interaction of ω-3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines.

C. Pichard, R. Miralbell, Y. Dupertuis, 2014, Clinical nutrition.

Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy.

R. Mirimanoff, M. Bolla, J. Bosset, 1993, International journal of radiation oncology, biology, physics.

Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.

E. Pedroni, A. Lomax, G. Goitein, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: Zelefsky J.M. et al , Urol 2014; 192: 868-874

R. Miralbell, T. Zilli, 2015 .

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Reto Meuli, Serge Leyvraz, Alessia Pica, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus.

M. Scorsetti, L. Livi, V. Fonteyne, 2021, Cancer treatment reviews.

First year experience with IORT for breast cancer at the Geneva University Hospitals

R. Miralbell, M. Castiglione‐Gertsch, V. Vinh-Hung, 2014 .

Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer.

R. Miralbell, H. Suit, C. Crowell, 1992, International journal of radiation oncology, biology, physics.

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study

Christophe Iselin, Raymond Miralbell, Roberto Zanetti, 2013, BMC Urology.

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence

H. Zaidi, O. Ratib, R. Miralbell, 2008, Nuklearmedizin.

Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer

R. Miralbell, A. Gelet, T. Hany, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004.

R. Miralbell, D. Weber, M. Rouzaud, 2009, Swiss medical weekly.

Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.

R. Miralbell, M. Rouzaud, M. Mollà, 2010, International journal of radiation oncology, biology, physics.

Total body irradiation before allogeneic bone marrow transplantation: is more dose better?

R. Miralbell, B. Chapuis, C. Helg, 2001, International journal of radiation oncology, biology, physics.

Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: spinal theca irradiation.

A. Lomax, A. Lomax, R. Miralbell, 1997, International journal of radiation oncology, biology, physics.

Kaposi's sarcoma following allogeneic bone marrow transplantation.

J. Saurat, R. Miralbell, D. Salomon, 1994, Bone marrow transplantation.

Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients

R. Rizzoli, C. Pichard, R. Miralbell, 2005, Bone Marrow Transplantation.

Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031.

Fran Laurie, Raymond Miralbell, Tianni Zhou, 2006, International journal of radiation oncology, biology, physics.

Reference [ ( 18 ) F ] Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma

H. Zaidi, O. Ratib, R. Miralbell, 2017 .

Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma

H. Zaidi, O. Ratib, R. Miralbell, 2008 .

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma

Habib Zaidi, Michel Rouzaud, Osman Ratib, 2008, Radiation oncology.

Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swiss Pediatric Oncology Group.

R. Miralbell, S. Bieri, P. Huguenin, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study

M. Usel, C. Iselin, R. Miralbell, 2014, BMC Urology.

High‐dose‐rate brachytherapy boost to the dominant intra‐prostatic tumor region: Hemi‐irradiation of prostate cancer

R. Miralbell, U. Schick, D. Weber, 2011, The Prostate.

Altered apoptotic profiles in irradiated patients with increased toxicity.

H. Blattmann, P. Coucke, O. Sanal, 1999, International journal of radiation oncology, biology, physics.

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.

S. Marnitz, R. Mirimanoff, R. Miralbell, 2003, International journal of radiation oncology, biology, physics.

Outcome and risk factors for late‐onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation

R. Miralbell, J. Passweg, M. Ansari, 2011, European journal of haematology.

Metastatic ependymoma of the sacrum

D. Louis, R. Miralbell, A. Rosenberg, 1990, Cancer.

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

M. Piérart, M. van Glabbeke, R. Mirimanoff, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Invasive bladder carcinoma: A pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin

R. Miralbell, M. Ozsahin, A. Roth, 2001, International journal of cancer.

Image-guided total-body irradiation with a movable electronic portal imaging device for bone marrow transplant conditioning.

Michel Rouzaud, Giovanna Dipasquale, Raymond Miralbell, 2019, Zeitschrift fur medizinische Physik.

Increased risk of colon cancer after external radiation therapy for prostate cancer

H. Verkooijen, R. Miralbell, R. Zanetti, 2008, International journal of cancer.

The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study.

R. Miralbell, G. Soete, G. Studer, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PET/MR in Breast Cancer.

Bénédicte M A Delattre, Osman Ratib, Raymond Miralbell, 2015, Seminars in nuclear medicine.

Quality of Life Outcomes After SBRT

R. Miralbell, T. Zilli, 2018, Stereotactic Radiosurgery for Prostate Cancer.

Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients

J. Bourhis, R. Miralbell, M. Ozsahin, 2018, Journal of Cancer Research and Clinical Oncology.

In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidance.

Michel Rouzaud, Giovanna Dipasquale, Raymond Miralbell, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy

C. Pichard, R. Miralbell, K. Weber, 2017, Acta oncologica.

Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors.

G. Vlastos, H. Verkooijen, M. Usel, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study

R. Miralbell, R. Zanetti, G. Fioretta, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Low-dose radiotherapy in indolent lymphoma.

R. Mirimanoff, R. Miralbell, M. Ozsahin, 2011, International journal of radiation oncology, biology, physics.

Prostate radiotherapy 18 F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer

Habib Zaidi, Osman Ratib, Michael Wissmeyer, 2009 .

Contouring workload in adjuvant breast cancer radiotherapy.

R Miralbell, R. Miralbell, V. Vinh-Hung, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

P167 Le support nutritionnel des patients atteints de cancer doit être optimisé

C. Pichard, P. Dulguerov, R. Miralbell, 2011 .

[Sexual health after radiotherapy].

R. Miralbell, F. Caparrotti, T. Zilli, 2018, Revue medicale suisse.

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?

R. Miralbell, N. Linthout, W. Verbakel, 2018, Radiation Oncology.

Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study.

R. Miralbell, D. Weber, M. Rouzaud, 2011, International journal of radiation oncology, biology, physics.

Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.

Michel Rouzaud, Haleem Khan, Carmen Ares, 2009, International journal of radiation oncology, biology, physics.

Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible?

R. Miralbell, M. Rouzaud, M. Mollà, 2004, International journal of radiation oncology, biology, physics.

Potential role of IMRT and protons in the treatment of the breast and regional nodes

A. Lomax, R. Miralbell, L. Cella, 2000 .

Potential improvement of three dimension treatment planning and proton beams in fractionated radiotherapy of large cerebral arteriovenous malformations.

M. Urie, R. Miralbell, R. Miralbell, 1993, International journal of radiation oncology, biology, physics.

FLASH and minibeams in radiation therapy: the effect of microstructures on time and space and their potential application to protontherapy

R. Miralbell, V. Favaudon, A. Mazal, 2020, The British journal of radiology.

Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.

R. Mirimanoff, M. Bolla, R. Miralbell, 1998, International journal of radiation oncology, biology, physics.

Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging

O. Ratib, R. Miralbell, V. Garibotto, 2016, Front. Oncol..

Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results

H. Minn, R. Miralbell, Z. Symon, 2020, Cancer medicine.

The exchange of radiotherapy data as part of an electronic patient-referral system.

A Lomax, O Ratib, R Miralbell, 2000, International journal of radiation oncology, biology, physics.

Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?

R. Miralbell, M. Rouzaud, M. Mollà, 2005, International journal of radiation oncology, biology, physics.

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9

John O. Prior, R. Miralbell, V. Garibotto, 2018, EJNMMI Research.

Improving 3D-printing of megavoltage X-rays radiotherapy bolus with surface-scanner

Giovanna Dipasquale, Raymond Miralbell, R. Miralbell, 2018, Radiation Oncology.

Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial.

M. Scorsetti, R. Miralbell, F. Alongi, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial

M. Scorsetti, R. Miralbell, F. Alongi, 2018, Radiation oncology.

Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapy

J. Vallée, R. Miralbell, F. Caparrotti, 2016, Acta oncologica.

Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity.

A. Lomax, D. Taussky, R. Miralbell, 2003, International journal of radiation oncology, biology, physics.

Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.

R. Miralbell, M. Rouzaud, T. Zilli, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

11C-acetate PET in the early evaluation of prostate cancer recurrence

Habib Zaidi, Osman Ratib, Dmitri Soloviev, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients

O. Ratib, R. Miralbell, V. Garibotto, 2015, Nuklearmedizin.

Moderate Hypofractionated Protracted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter?

R. Miralbell, M. Rouzaud, T. Zilli, 2016, International journal of radiation oncology, biology, physics.

RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study

Habib Zaidi, Michel Rouzaud, Osman Ratib, 2009, Radiation oncology.

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT

O. Ratib, R. Miralbell, F. Buchegger, 2012, Radiation oncology.

Breathing adapted radiotherapy: a 4D gating software for lung cancer

Habib Zaidi, Osman Ratib, Michael Wissmeyer, 2011, Radiation oncology.

Fractionation sensitivity and immunological status in radiation treated murine sarcomas.

P. Okunieff, A. Zietman, H. Thames, 1990, International journal of radiation oncology, biology, physics.

Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?

R. Miralbell, M. Rouzaud, T. Zilli, 2019, Journal of Cancer Research and Clinical Oncology.

The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers

R. Miralbell, A. Allal, B. Mermillod, 1999, Strahlentherapie und Onkologie.

Characteristics and outcome of prostate cancer with PSA

R. Miralbell, R. Zanetti, G. Fioretta, 2018 .

Planning for the future: cancer incidence projections in Switzerland up to 2019

M. Usel, R. Miralbell, E. Rapiti, 2014, BMC Public Health.

Electromagnetic transponders localization and real-time tracking for prostate cancer radiotherapy: clinical impact of metallic hip prostheses.

R. Miralbell, M. Jaccard, A. Lancia, 2020, Practical radiation oncology.

Long-Term Post-Treatment MR and PET/CT Imaging in Prostate Cancer Patients in Complete Remission after Curative Radiotherapy with or without Androgen Deprivation: The Image of Cure

O. Ratib, Y. Seimbille, R. Miralbell, 2012 .

Radiotherapy for supratentorial low-grade gliomas: results and prognostic factors with special focus on tumour volume parameters.

R. Miralbell, X. Matías-Guiu, J. Molet, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

PP037-MON AN EARLY NUTRITION-EXERCISE PROGRAM CAN POSITIVELY AFFECT THE BODY COMPOSITION AND PHYSICAL FUNCTION (PF) OF FRAIL PROSTATE CANCER PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY (ADT)

C. Pichard, R. Miralbell, T. Zilli, 2012 .

Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume.

T. Bortfeld, A. Lomax, A. Lomax, 1997, International journal of radiation oncology, biology, physics.

Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.

A. Lomax, R. Miralbell, L. Cella, 2003, International journal of radiation oncology, biology, physics.

Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangement.

R. Miralbell, M. Ozsahin, M. Rouzaud, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.

Michel Rouzaud, Haleem Khan, Alberto Hidalgo, 2007, International journal of radiation oncology, biology, physics.

Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?

R. Miralbell, T. Zilli, C. Picardi, 2018, Cancer treatment reviews.

Potential role of intensity modulated proton beams in prostate cancer radiotherapy.

R Miralbell, A. Lomax, R. Miralbell, 2001, International journal of radiation oncology, biology, physics.

Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.

H. Minn, R. Miralbell, N. Linthout, 2020, International journal of radiation oncology, biology, physics.

Stereotactic beam radiotherapy for prostate cancer: is less, more?

R. Miralbell, 2019, The Lancet. Oncology.

Patient positioning in prostate radiotherapy: is prone better than supine?

R. Miralbell, D. Weber, M. Rouzaud, 2000, International journal of radiation oncology, biology, physics.

POTENTIAL ROLE OF PROTON THERAPY IN THE TREATMENT OF PEDIATRIC MEDULLOBLASTOMAIPRIMITIVE ~~OE~~L TUMORS: REDUCTION OF TI-IE SUPRATENTORIAL TARGET VOLUME

T. Bortfeld, A. Lomax, R. Miralbell, 1997 .

[Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network].

R. Miralbell, G. Soete, G. Studer, 2004, Bulletin du cancer.

Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma.

R. Miralbell, A. Allal, W. Lehmann, 1997, Acta oncologica.

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist

John O. Prior, R. Miralbell, V. Garibotto, 2019 .

New techniques in hadrontherapy: intensity modulated proton beams.

A. Lomax, R. Miralbell, L. Cella, 2001, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients

H. Zaidi, O. Ratib, R. Miralbell, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis

R. Miralbell, N. Péguret, F. Caparrotti, 2014, Acta oncologica.

A modelled comparison of prostate cancer control rates after high-dose-rate brachytherapy (3145 multicentre patients) combined with, or in contrast to, external-beam radiotherapy.

J. Fowler, J. Hendry, R. Miralbell, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dosimetric implications of changes in patient repositioning and organ motion in conformal radiotherapy for prostate cancer.

Michel Rouzaud, Raymond Miralbell, Philippe Nouet, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients

L. Cozzi, R. Miralbell, H. Vees, 2015, Technology in Cancer Research and Treatment.